Accelerate Diagnostics to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 18, 2020, at 4:00 p.m. Eastern Time

Rhea-AI Summary

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) will present virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 18, 2020, at 4:00 p.m. Eastern Time. A live audiocast will be available on the company’s investor relations website, with a replay provided for at least 30 days post-conference.

The company focuses on combating antibiotic resistance and sepsis through its Accelerate Pheno® system and Accelerate PhenoTest® BC kit, delivering phenotypic antibiotic susceptibility results in approximately 7 hours.

TUCSON, Ariz., Feb. 1, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that the company is scheduled to present virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 18, 2020, at 4:00 p.m. Eastern Time.

A live audiocast of the session will be accessible through the company's investor relations website at ir.axdx.com. A replay of the audiocast will be available for at least 30 days following the conference.

About Accelerate Diagnostics, Inc.

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for serious infections. The FDA-cleared system and kit fully automate sample preparation steps, enabling phenotypic antibiotic susceptibility results in about 7 hours directly from positive blood cultures. Recent external studies indicate the solution offers results 1 to 2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient's infection, days earlier.

The "ACCELERATE DIAGNOSTICS" and "ACCELERATE PHENO" and "ACCELERATE PHENOTEST" and diamond shaped logos and marks are registered trademarks of Accelerate Diagnostics, Inc.

For more information about the company, its products and technology, or recent publications, visit axdx.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/accelerate-diagnostics-to-participate-in-btig-medtech-digital-health-life-science--diagnostic-tools-conference-on-february-18-2020-at-400-pm-eastern-time-301218594.html

SOURCE Accelerate Diagnostics, Inc.

FAQ

What is the date and time of the Accelerate Diagnostics presentation at the BTIG conference?

The presentation is scheduled for February 18, 2020, at 4:00 p.m. Eastern Time.

Where can I access the live audiocast of Accelerate Diagnostics' conference presentation?

The live audiocast can be accessed through the company's investor relations website at ir.axdx.com.

How long will the replay of the Accelerate Diagnostics audiocast be available?

The replay will be available for at least 30 days following the conference.

What technologies does Accelerate Diagnostics utilize to address antibiotic resistance?

Accelerate Diagnostics employs the Accelerate Pheno® system and the Accelerate PhenoTest® BC kit.

How quickly can the Accelerate PhenoTest deliver antibiotic susceptibility results?

The test provides results in about 7 hours from positive blood cultures, significantly faster than existing methods.